Annual Biosimilars Summit

June 2015



InterContinental Hotel Berlin

Budapester Str. 2, 10787

About Summit

This premier B2B event will enable the participants to explore strategies for overcoming scientific, regulatory and legal challenges in the development and commercialization of biosimilars through technical case studies and practical advice from leading biosimilar and regulatory players.

Who Should Attend

Chief Executives, Executive Directors, VPs, Department Heads, Team Leaders and Managers from:

  • Biologics/Biotechnology/ Biogenerics
  • Market Strategy
  • Regulatory Affairs
  • Preclinical and Clinical Development
  • Regulatory Strategy
  • Pricing and Reimbursement
  • Quality Affairs / Quality Control
  • Commercial Affairs
  • Biopharmaceuticals / Biotherapeutics
  • Portfolio Development
  • R&D
  • Regulatory Compliance
  • New Product Development
  • Clinical Immunology
  • Business Development
  • Marketing & Sales
Key Practical Learning Points of the Summit

The European Biosimilar landscape, what does the future hold: challenges & expectations
The commercial game and how to play commercial strategy to increase market uptake
Forecasting biosimilar product portfolios and effectively planning and realigning business strategies for future changes
Facilitating the acceptance and increasing the uptake of biosimilars
The experience exchange: developing and introducing biosimilars to new markets
Overview of Global R&D and regulatory landscape
Dr. Rodeina Challand

Executive Director, Biosimilars Development – Scientific Affairs


Dr. Beatrix Metzner

Director CMC Expert and Tech RA

Boehringer Ingelheim Pharma GmbH & Co. KG

Catherine Godrecka-Bareau

Director Portfolio Management & Strategy – Biosimilars




Sponsors and Partners